MHC class II 11-associated invariant chain isoforms regulate pulmonary immune responses

Journal of Immunology

Volumn 170, Issue 3, 2003, Pages 1473-1480

  Ye, Qiang ^a   Finn, Patricia W ^a   Sweeney, Ruth ^a   Bikoff, Elizabeth K ^b   Riese, Richard J ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD UNIVERSITY   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; CHAPERONE; IMMUNOGLOBULIN E; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

AIRWAY OBSTRUCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; EOSINOPHILIA; IMMUNE RESPONSE; IMMUNITY; IMMUNOGLOBULIN PRODUCTION; IMMUNOREGULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SENSITIZATION; T LYMPHOCYTE ACTIVATION;

EID: 0037309188     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.170.3.1473     Document Type: Article

References (63)

1. Cresswell, P. 1994. Assembly, transport, and function of MHC class II molecules. Annu. Rev. Immunol. 12:259.
2. Germain, R. N. 1994. MHC-dependent antigen processing and peptide presentation: Providing ligands for T lymphocyte activation. Cell 76:287.
3. Watts, C. 1997. Capture and processing of exogenous antigens for presentation on MHC molecules. Annu. Rev. Immunol. 15:821.
4. Wolf, P. R., and H. L. Ploegh. 1995. How MHC class II molecules acquire peptide cargo: Biosynthesis and trafficking through the endocytic pathway. Annu. Rev. Cell. Dev. Biol. 11:267.
5. Riese, R. J., and H. A. Chapman. 2000. Cathepsins and compartmentalization in antigen presentation. Curr. Opin. Immunol. 12:107.
6. Riese, R. J., P. R. Wolf, D. Bromme, L. R. Natkin, J. A. Villadangos, H. L. Ploegh, and H. A. Chapman. 1996. Essential role for cathepsin S in MHC class II-associated invariant chain processing and peptide loading. Immunity 4:357.
7. Villadangos, J. A., R. J. Riese, C. Peters, H. A. Chapman, and H. L. Ploegh. 1997. Degradation of mouse invariant chain: Roles of cathepsins S and D and the influence of major histocompatibility complex polymorphism. J. Exp. Med. 186:549.
8. Villadangos, J. A., R. A. Bryant, J. Deussing, C. Driessen, A. M. Lennon-Dumenil, R. J. Riese, W. Roth, P. Saftig, G. P. Shi, H. A. Chapman, et al. 1999. Proteases involved in MHC class II antigen presentation. Immunol. Rev. 172:109.
9. Sloan, V. S., P. Cameron, G. Porter, M. Gammon, M. Amaya, E. Mellins, and D. M. Zaller. 1995. Mediation by HLA-DM of dissociation of peptides from HLA-DR. Nature 375:802.
10. Sherman, M. A., D. A. Weber, and P. E. Jensen. 1995. DM enhances peptide binding to class II MHC by release of invariant chain-derived peptide. Immunity 3:197.
11. Ghosh, P., M. Amaya, E. Mellins, and D. C. Wiley. 1995. The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3. Nature 378:457.
12. Fung-Leung, W. P., C. D. Surh, M. Liljedahl, J. Pang, D. Leturcq, P. A. Peterson, S. R. Webb, and L. Karlsson. 1996. Antigen presentation and T cell development in H2-M-deficient mice. Science 271:1278.
13. Miyazaki, T., P. Wolf, S. Tourne, C. Waltzinger, A. Dierich, N. Barois, H. Ploegh, C. Benoist, and D. Mathis. 1996. Mice lacking H2-M complexes, enigmatic elements of the MHC class II peptide-loading pathway. Cell 84:531.
14. Viville, S., J. Neefjes, V. Lotteau, A. Dierich, M. Lemeur, H. Ploegh, C. Benoist, and D. Mathis. 1993. Mice lacking the MHC class II-associated invariant chain. Cell 72:635.
15. + T cell selection in mice lacking invariant chain expression. J. Exp. Med. 177:1699.
16. Elliott, E. A., J. R. Drake, S. Amigorena, J. Elsemore, P. Webster, I. Mellman, and R. A. Flavell. 1994. The invariant chain is required for intracellular transport and function of major histocompatibility complex class II molecules. J. Exp. Med. 179:681.
17. Martin, W. D., G. G. Hicks, S. K. Mendiratta, H. I. Leva, H. E. Ruley, and L. Van Kaer. 1996. H2-M mutant mice are defective in the peptide loading of class II molecules, antigen presentation, and T cell repertoire selection. Cell 84:543.
18. Bikoff, E. K., R. N. Germain, and E. J. Robertson. 1995. Allelic differences affecting invariant chain dependency of MHC class II subunit assembly. Immunity 2:301.
19. Shachar, I., and R. A. Flavell. 1996. Requirement for invariant chain in B cell maturation and function. Science 274:106.
20. Topilski, I., A. Harmelin, R. A. Flavell, Y. Levo, and I. Shachar. 2002. Preferential Th1 immune response in invariant chain-deficient mice. J. Immunol. 168:1610.
21. Matza, D., O. Wolstein, R. Dikstein, and I. Shachar. 2001. Invariant chain induces B cell maturation by activating a TAF(II)105-NF-κB-dependent transcription program. J. Biol. Chem. 276:27203.
22. Matza, D., F. Lantner, Y. Bogoch, L. Flaishon, R. Hershkoviz, and I. Shachar. 2002. Invariant chain induces B cell maturation in a process that is independent of its chaperonic activity. Proc. Natl. Acad. Sci. USA 99:3018.
23. Strubin, M., C. Berte, and B. Mach. 1986. Alternative splicing and alternative initiation of translation explain the four forms of the Ia antigen-associated invariant chain. EMBO J. 5:3483.
24. Koch, N., W. Lauer, J. Habicht, and B. Dobberstein. 1987. Primary structure of the gene for the murine Ia antigen-associated invariant chains (Ii): an alternatively spliced exon encodes a cysteine-rich domain highly homologous to a repetitive sequence of thyroglobulin. EMBO J. 6:1677.
25. O'Sullivan, D. M., D. Noonan, and V. Quaranta. 1987. Four Ia invariant chain forms derive from a single gene by alternate splicing and alternate initiation of transcription/translation. J. Exp. Med. 166:444.
26. Romagnoli, P., C. Layet, J. Yewdell, O. Bakke, and R. N. Germain. 1993. Relationship between invariant chain expression and major histocompatibility complex class II transport into early and late endocytic compartments. J. Exp. Med. 177:583.
27. Arunachalam, B., C. A. Lamb, and P. Cresswell. 1994. Transport properties of free and MHC class II-associated oligomers containing different isoforms of human invariant chain. Int. Immunol. 6:439.
28. Stockinger, B., U. Pessara, R. H. Lin, J. Habicht, M. Grez, and N. Koch. 1989. A role of Ia-associated invariant chains in antigen processing and presentation. Cell 56:683.
29. + T cell function in mice lacking the p41 isoform of invariant chain. Immunity 3:385.
30. Ogrinc, T., I. Dolenc, A. Ritonja, and V. Turk. 1993. Purification of the complex of cathepsin L and the MHC class II-associated invariant chain fragment from human kidney. FEBS Lett. 336:555.
31. Bevec, T., V. Stoka, G. Pungercic, I. Dolenc, and V. Turk. 1996. Major histocompatibility complex class lI-associated p41 invariant chain fragment is a strong inhibitor of lysosomal cathepsin L. J. Exp. Med. 183:1331.
32. Lennon-Dumenil, A. M., R. A. Roberts, K. Vatentijn, C. Driessen, H. S. Overkleeft, A. Erickson, P. J. Peters, E. Bikoff, H. L. Ploegh, and P. Wolf Bryant. 2001. The p41 isoform of invariant chain is a chaperone for cathepsin L. EMBO J. 20:4055.
33. Peterson, M., and J. Miller. 1992. Antigen presentation enhanced by the alternatively spliced invariant chain gene product p41. Nature 357:596.
34. Fineschi, B., K. Sakaguchi, E. Appella, and J. Miller. 1996. The proteolytic environment involved in MHC class II-restricted antigen presentation can be modulated by the p41 form of invariant chain. J. Immunol. 157:3211.
35. Slavin, A. J., J. M. Soos, O. Stuve, J. C. Patarroyo, H. L. Weiner, A. Fontana, E. K. Bikoff, and S. S. Zamvil. 2001. Requirement for endocytic antigen processing and influence of invariant chain and H-2M deficiencies in CNS autoimmunity. J. Clin. Invest. 108:1133.
36. Bikoff, E. K., G. Kenty, and L. Van Kaer. 1998. Distinct peptide loading pathways for MHC class II molecules associated with alternative Ii chain isoforms. J. Immunol. 160:3101.
37. Alfonso, C., J. O. Han, G. S. Williams, and L. Karlsson. 2001. The impact of H2-DM on humoral immune responses. J. Immunol. 167:6348.
38. Swier, K., D. R. Brown, J. J. Bird. W. D. Martin, L. Van Kaer, and S. L. Reiner. 1998. A critical, invariant chain-independent role for H2-M in antigen presentation. J. Immunol. 160:540.
39. Krinzman, S. J., G. T. De Sanctis, M. Cernadas, L. Kobzik, J. A. Listman, D. C. Christiani, D. L. Perkins, and P. W. Finn. 1996. Tcell activation in a murine model of asthma. Am. J. Physiol. 271:L476.
40. Lambrecht, B. N., B. Salomon, D. Klatzmann, and R. A. Pauwels. 1998. Dendritic cells are required for the development of chronic eosinophilic airway inflammation in response to inhaled antigen in sensitized mice. J. Immunol. 160:4090.
41. Takaesu, N. T., J. A. Lower, D. Yelon, E. J. Robertson, and E. K. Bikoff. 1997. In vivo functions mediated by the p41 isoform of the MHC class II-associated invariant chain. J. Immunol. 158:187.
42. Bikoff, E. K. 1992. Formation of complexes between self-peptides and MHC class II molecules in cells defective for presentation of exogenous protein antigens. J. Immunol. 149:1.
43. Hamelmann, E., J. Schwarze, K. Takeda, A. Oshiba, G. L. Larsen, C. G. Irvin, and E. W. Gelfand. 1997. Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am. J. Respir. Crit. Care Med. 156:766.
44. Fleming, C. M., H. He, A. Ciota, D. Perkins, and P. W. Finn. 2001. Administration of pentoxifylline during allergen sensitization dissociates pulmonary allergic inflammation from airway hyperresponsiveness. J. Immunol. 167:1703.
45. Momburg, F., N. Koch, P. Moller, G. Moldenhauer, G. W. Butcher, and G. J. Hammerling. 1986. Differential expression of Ia and Ia-associated invariant chain in mouse tissues after in vivo treatment with IFN-γ. J. Immunol. 136:940.
46. Milgrom, H., R. B. Fick, Jr., J. Q. Su, J. D. Reimann, R. K. Bush, M. L. Watrous, and W. J. Metzger. 1999. Treatment of allergic asthma with monoclonal anti-IgE antibody: rhuMAb-E25 Study Group. N. Engl. J. Med. 341:1966.
47. Hamelmann, E., K. Tadeda, A. Oshiba, and E. W. Gelfand. 1999. Role of IgE in the development of allergic airway inflammation and airway hyperresponsiveness: a murine model. Allergy 54:297.
48. Hamelmann, E., U. Wahn, and E. W. Gelfand. 1999. Role of the Th2 cytokines in the development of allergen-induced airway inflammation and hyperresponsiveness. Int. Arch. Allergy Immunol. 118:90.
49. Makela, M. J., A. Kanehiro, L. Borish, A. Dakhama, J. Loader, A. Joetham, Z. Xing, M. Jordana, G. L. Larsen, and E. W. Gelfand. 2000. IL-10 is necessary for the expression of airway hyperresponsiveness but not pulmonary inflammation after allergic sensitization. Proc. Natl. Acad. Sci. USA 97:6007.
50. Brown, D. R., K. Swier, N. H. Moskowitz, M. F. Naujokas, R. M. Locksley, and S. L. Reiner. 1997. T helper subset differentiation in the absence of invariant chain. J. Exp. Med. 185:31.
51. Hsieh, C. S., P. deRoos, K. Honey, C. Beers, and A. Y. Rudensky. 2002. A role for cathepsin L and cathepsin S in peptide generation for MHC class II presentation. J. Immunol. 168:2618.
52. Siebenkotten, I. M., C. Carstens, and N. Koch. 1998. Identification of a sequence that mediates promiscuous binding of invariant chain to MHC class II allotypes. J. Immunol. 160:3355.
53. Wilson, N. A., P. Wolf, H. Ploegh, L. Ignatowicz, J. Kappler, and P. Marrack. 1998. Invariant chain can bind MHC class II at a site other than the peptide binding groove. J. Immunol. 161:4777.
54. Thayer, W. P., L. Ignatowicz, D. A. Weber, and P. E. Jensen. 1999. Class II-associated invariant chain peptide-independent binding of invariant chain to class II MHC molecules. J. Immunol. 162:1502.
55. Castellino, F., R. Han, and R. N. Germain. 2001. The transmembrane segment of invariant chain mediates binding to MHC class II molecules in a CLIP-independent manner. Eur. J. Immunol. 31:841.
56. Krinzman, S. J., G. T. De Sanctis, M. Cernadas, D. Mark, Y. Wang, J. Listman, L. Kobzik, C. Donovan, K. Nassr, I. Katona, et al. 1996. Inhibition of T cell costimulation abrogates airway hyperresponsiveness in a murine model. J. Clin. Invest. 98:2693.
57. Cernadas, M., G. T. De Sanctis, S. J. Krinzman, D. A. Mark, C. E. Donovan, J. A. Listman, L. Kobzik, H. Kikutani, D. C. Christiani, D. L. Perkins, and P. W. Finn. 1999. CD23 and allergic pulmonary inflammation: potential role as an inhibitor. Am. J. Respir. Cell Mol. Biol. 20:1.
58. Haczku, A., K. Takeda, E. Hamelmann, J. Loader, A. Joetham, I. Redai, C. G. Irvin, J. J. Lee, H. Kikutani, D. Conrad, and E. W. Gelfand. 2000. CD23 exhibits negative regulatory effects on allergic sensitization and airway hyperresponsiveness. Am. J. Respir. Crit. Care Med. 161:952.
59. Haczku, A., K. Takeda, I. Redai, E. Hamelmann, G. Cieslewicz, A. Joetham, J. Loader, J. J. Lee, C. Irvin, and E. W. Gelfand. 1999. Anti-CD86 (B7.2) treatment abolishes allergic airway hyperresponsiveness in mice. Am. J. Respir. Crit. Care Med 109:1638.
60. Crimi, E., A. Spanevello, M. Neri, P. W. Ind, G. A. Rossi, and V. Brusasco. 1998. Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma. Am. J. Respir. Crit Care Med. 157:4.
61. Wilder, J. A., D. D. Collie, B. S. Wilson, D. E. Bice, C. R. Lyons, and M. F. Lipscomb. 1999. Dissociation of airway hyperresponsiveness from immunoglobulin E and airway eosinophilia in a murine model of allergic asthma. Am. J. Respir. Cell Mol. Biol. 20:1326.
62. Lilly, C. M., R. W. Chapman, S. J. Sehring, P. J. Mauser, R. W. Egan, and J. M. Drazen. 1996. Effects of interleukin 5-induced pulmonary eosinophilia on airway reactivity in the guinea pig. Am. J. Physiol. 270:L368.
63. Sung, S., C. E. Rose, and S. M. Fu. 2001. Intratracheal priming with ovalbumin and ovalbumin 323-339 peptide-pulsed dendritic cells induces airway hyperresponsiveness, lung eosinophilia, goblet cell hyperplasia, and inflammation. J. Immunol. 166:1261.